AI

Technology

Last mentioned: Mar 26, 2026

Stories mentioning AI 4

pharma Very Bullish

Cearvol Debuts Wave: AI-Powered Touchscreen Hearing Solution for Daily Use

Cearvol has officially launched Wave, a professional-grade hearing aid that integrates artificial intelligence and a touchscreen interface. This award-winning device aims to improve accessibility and user confidence for millions suffering from hearing loss through real-time environmental adaptation.

2 sources
funding Neutral

SpendRule Exits Stealth with $2M to Tackle Hospital Spending Inefficiency

SpendRule has secured $2M in seed funding to launch its AI-powered platform designed to provide healthcare systems with real-time visibility into operational expenditures. The startup aims to eliminate 'dark spend' and administrative waste within the fragmented financial ecosystems of modern hospitals.

2 sources
pharma Bullish

Merck and Mayo Clinic Launch AI-Driven Drug Discovery Collaboration

Merck and Mayo Clinic have entered a multi-year research and development collaboration to leverage artificial intelligence for drug discovery and personalized patient care. The partnership integrates Merck's pharmaceutical expertise with Mayo Clinic's clinical data and AI capabilities to accelerate the development of targeted therapies.

2 sources
pharma Bullish

Doceree Launches AI-Powered Admanager to Transform Healthcare Publishing

Doceree has unveiled Admanager, an AI-driven platform specifically engineered to empower healthcare publishers in managing their digital advertising ecosystems. The tool aims to streamline HCP targeting and data sovereignty, addressing long-standing inefficiencies in the pharmaceutical marketing supply chain.

2 sources

About AI coverage

This page surfaces every story mentioning AI across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where AI was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.